Tech Company Financing Transactions

Logical Therapeutics Funding Round

Burrill & Company, Novo Ventures and SV Health Investors participated in a $6 million venture round for Logical Therapeutics. The round was announced on 12/31/2008.

Transaction Overview

Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors

Burrill & Company (Ann Hanham)

Novo Ventures (Martin Edwards)

SV Health Investors (Lutz Giebel)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
124 Washington St. 101
Foxboro, MA 02035
USA
Email Address
Overview
The company is developing medicines to treat diseases that are associated with poorly controlled or excessive inflammation.
Profile
Logical Therapeutics LinkedIn Company Profile
Social Media
Logical Therapeutics Company Twitter Account
Company News
Logical Therapeutics News
Facebook
Logical Therapeutics on Facebook
YouTube
Logical Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Co-Founder
Lutz Giebel
  Lutz Giebel LinkedIn Profile  Lutz Giebel Twitter Account  Lutz Giebel News  Lutz Giebel on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2008: OxyPlus venture capital transaction
Next: 12/31/2008: Body Beam Research venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary